We believe in being the change we wish to see in the world.
Artrya Ltd
Mathew Regan
Mr Regan is an experienced executive who has worked in a variety of Industries including ASX listed companies, Private Equity and Cooperatives. He has worked in multi-disciplinary environments from supply…
John Konstantopoulos
With the skills gained providing strategic advice to boards and executives globally on the impact of digital disruption, John Konstantopoulos is instrumental in Artrya’s pursuit to help solve coronary artery disease.
Mark Wainwright
An experienced online business builder and Chartered Accountant, Mark co-founded, led and grew two cutting-edge online businesses and has broad experience across all aspects of establishing and growing start-ups in the exciting, highly competitive and fast-moving tech sector.
Dr Jacob Agris
Dr Agris is a senior healthcare executive, thought leader and accomplished physician with computer engineering doctoral studies in analytics and machine learning.
Professor Girish Dwivedi, MD
As Artrya’s Chief Scientific Officer, Professor Girish Dwivedi, MD is excited to be working within the MedTech industry to innovate and create solutions using advanced technology, such as AI, to improve health.
Dr Abdul Rahman Ihdayhid
As a leader in coronary artery disease diagnosis and treatment, Dr. Ihdayhid uses his practical and academic knowledge to inform Artrya’s research and development, including testing and validating product accuracy and efficacy. He also assists with clinical education and awareness and is a key opinion leader on the benefits of early, non-invasive coronary artery disease diagnosis.